| Steven G Wilson, CRNA | |
|
1111 Ronald Reagan Pkwy, Avon, IN 46123-7085 | |
| (317) 577-4200 | |
| (317) 577-4200 |
| Full Name | Steven G Wilson |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 7 Years |
| Location | 1111 Ronald Reagan Pkwy, Avon, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922533009 | NPI | - | NPPES |
| 264430H09 | Other | IN | MEDICARE |
| 300005735 | Medicaid | IN | |
| 095200132 | Other | IN | MEDICARE PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 28280811A (Indiana) | Primary |
| 367500000X | Nurse Anesthetist, Certified Registered | APRNCRNA019502 (Ohio) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Christ Hospital | Cincinnati, OH | Hospital |
| Fort Hamilton Hughes Memorial Hospital | Hamilton, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anesthesia Associates Of Cincinnati, Inc | 4789598509 | 115 |
| Dayton Anesthesia And Pain Services Llc | 8022245372 | 195 |
News Archive
New exchange plan enrollees spent less on medications in the first quarter of 2015 compared to the same time a year ago, according to the third edition of the Express Scripts Exchange Pulse report, released today.
Overweight or obese women with the mentality that they are "eating for two" are more likely to experience excessive weight gain while pregnant, according to researchers at Penn State College of Medicine.
According to Simon Stevens, Chief Executive of NHS England, the NHS is looking at an epidemic of mental ill health among children and teenagers as an after effect of social media.
GenSpera, Inc. announced today that the Institutional Review Board (IRB) at the University of Wisconsin, in Madison, WI, has approved a Phase I study of its target activated pro-drug, G-202, for the treatment of cancer. The FDA (US Food and Drug Administration) approved the study in September. GenSpera expects to enroll the first study patient early in the first quarter of 2010.
Rosetta Genomics, Ltd., a leading developer and provider of microRNA-based molecular diagnostics, announces that results from a joint study by researchers at the Institutes of Oncology, Davidoff Center, Rabin Medical Center, Beilinson Hospital and Golda-Hasharon Hospital in Petach-Tikva, Israel show that in post-resection gastric cancer patients microRNAs may serve to predict the risk of recurrence.
› Verified 9 days ago
| Entity Name | University Of Cincinnati Physicians Company Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801840434 PECOS PAC ID: 2264344480 Enrollment ID: O20031105000123 |
News Archive
New exchange plan enrollees spent less on medications in the first quarter of 2015 compared to the same time a year ago, according to the third edition of the Express Scripts Exchange Pulse report, released today.
Overweight or obese women with the mentality that they are "eating for two" are more likely to experience excessive weight gain while pregnant, according to researchers at Penn State College of Medicine.
According to Simon Stevens, Chief Executive of NHS England, the NHS is looking at an epidemic of mental ill health among children and teenagers as an after effect of social media.
GenSpera, Inc. announced today that the Institutional Review Board (IRB) at the University of Wisconsin, in Madison, WI, has approved a Phase I study of its target activated pro-drug, G-202, for the treatment of cancer. The FDA (US Food and Drug Administration) approved the study in September. GenSpera expects to enroll the first study patient early in the first quarter of 2010.
Rosetta Genomics, Ltd., a leading developer and provider of microRNA-based molecular diagnostics, announces that results from a joint study by researchers at the Institutes of Oncology, Davidoff Center, Rabin Medical Center, Beilinson Hospital and Golda-Hasharon Hospital in Petach-Tikva, Israel show that in post-resection gastric cancer patients microRNAs may serve to predict the risk of recurrence.
› Verified 9 days ago
| Entity Name | Anesthesia Associates Of Cincinnati, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316945173 PECOS PAC ID: 4789598509 Enrollment ID: O20031117000374 |
News Archive
New exchange plan enrollees spent less on medications in the first quarter of 2015 compared to the same time a year ago, according to the third edition of the Express Scripts Exchange Pulse report, released today.
Overweight or obese women with the mentality that they are "eating for two" are more likely to experience excessive weight gain while pregnant, according to researchers at Penn State College of Medicine.
According to Simon Stevens, Chief Executive of NHS England, the NHS is looking at an epidemic of mental ill health among children and teenagers as an after effect of social media.
GenSpera, Inc. announced today that the Institutional Review Board (IRB) at the University of Wisconsin, in Madison, WI, has approved a Phase I study of its target activated pro-drug, G-202, for the treatment of cancer. The FDA (US Food and Drug Administration) approved the study in September. GenSpera expects to enroll the first study patient early in the first quarter of 2010.
Rosetta Genomics, Ltd., a leading developer and provider of microRNA-based molecular diagnostics, announces that results from a joint study by researchers at the Institutes of Oncology, Davidoff Center, Rabin Medical Center, Beilinson Hospital and Golda-Hasharon Hospital in Petach-Tikva, Israel show that in post-resection gastric cancer patients microRNAs may serve to predict the risk of recurrence.
› Verified 9 days ago
| Entity Name | Southwest Ohio Anesthesia Consultants Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588645188 PECOS PAC ID: 6901700640 Enrollment ID: O20031124000399 |
News Archive
New exchange plan enrollees spent less on medications in the first quarter of 2015 compared to the same time a year ago, according to the third edition of the Express Scripts Exchange Pulse report, released today.
Overweight or obese women with the mentality that they are "eating for two" are more likely to experience excessive weight gain while pregnant, according to researchers at Penn State College of Medicine.
According to Simon Stevens, Chief Executive of NHS England, the NHS is looking at an epidemic of mental ill health among children and teenagers as an after effect of social media.
GenSpera, Inc. announced today that the Institutional Review Board (IRB) at the University of Wisconsin, in Madison, WI, has approved a Phase I study of its target activated pro-drug, G-202, for the treatment of cancer. The FDA (US Food and Drug Administration) approved the study in September. GenSpera expects to enroll the first study patient early in the first quarter of 2010.
Rosetta Genomics, Ltd., a leading developer and provider of microRNA-based molecular diagnostics, announces that results from a joint study by researchers at the Institutes of Oncology, Davidoff Center, Rabin Medical Center, Beilinson Hospital and Golda-Hasharon Hospital in Petach-Tikva, Israel show that in post-resection gastric cancer patients microRNAs may serve to predict the risk of recurrence.
› Verified 9 days ago
| Entity Name | Ogi Anesthesia, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962776807 PECOS PAC ID: 8224290598 Enrollment ID: O20120502000531 |
News Archive
New exchange plan enrollees spent less on medications in the first quarter of 2015 compared to the same time a year ago, according to the third edition of the Express Scripts Exchange Pulse report, released today.
Overweight or obese women with the mentality that they are "eating for two" are more likely to experience excessive weight gain while pregnant, according to researchers at Penn State College of Medicine.
According to Simon Stevens, Chief Executive of NHS England, the NHS is looking at an epidemic of mental ill health among children and teenagers as an after effect of social media.
GenSpera, Inc. announced today that the Institutional Review Board (IRB) at the University of Wisconsin, in Madison, WI, has approved a Phase I study of its target activated pro-drug, G-202, for the treatment of cancer. The FDA (US Food and Drug Administration) approved the study in September. GenSpera expects to enroll the first study patient early in the first quarter of 2010.
Rosetta Genomics, Ltd., a leading developer and provider of microRNA-based molecular diagnostics, announces that results from a joint study by researchers at the Institutes of Oncology, Davidoff Center, Rabin Medical Center, Beilinson Hospital and Golda-Hasharon Hospital in Petach-Tikva, Israel show that in post-resection gastric cancer patients microRNAs may serve to predict the risk of recurrence.
› Verified 9 days ago
| Entity Name | Dayton Anesthesia & Pain Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629401898 PECOS PAC ID: 8022245372 Enrollment ID: O20131212001655 |
News Archive
New exchange plan enrollees spent less on medications in the first quarter of 2015 compared to the same time a year ago, according to the third edition of the Express Scripts Exchange Pulse report, released today.
Overweight or obese women with the mentality that they are "eating for two" are more likely to experience excessive weight gain while pregnant, according to researchers at Penn State College of Medicine.
According to Simon Stevens, Chief Executive of NHS England, the NHS is looking at an epidemic of mental ill health among children and teenagers as an after effect of social media.
GenSpera, Inc. announced today that the Institutional Review Board (IRB) at the University of Wisconsin, in Madison, WI, has approved a Phase I study of its target activated pro-drug, G-202, for the treatment of cancer. The FDA (US Food and Drug Administration) approved the study in September. GenSpera expects to enroll the first study patient early in the first quarter of 2010.
Rosetta Genomics, Ltd., a leading developer and provider of microRNA-based molecular diagnostics, announces that results from a joint study by researchers at the Institutes of Oncology, Davidoff Center, Rabin Medical Center, Beilinson Hospital and Golda-Hasharon Hospital in Petach-Tikva, Israel show that in post-resection gastric cancer patients microRNAs may serve to predict the risk of recurrence.
› Verified 9 days ago
| Entity Name | Cgi Anesthesia Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174914352 PECOS PAC ID: 0840518411 Enrollment ID: O20150410000268 |
News Archive
New exchange plan enrollees spent less on medications in the first quarter of 2015 compared to the same time a year ago, according to the third edition of the Express Scripts Exchange Pulse report, released today.
Overweight or obese women with the mentality that they are "eating for two" are more likely to experience excessive weight gain while pregnant, according to researchers at Penn State College of Medicine.
According to Simon Stevens, Chief Executive of NHS England, the NHS is looking at an epidemic of mental ill health among children and teenagers as an after effect of social media.
GenSpera, Inc. announced today that the Institutional Review Board (IRB) at the University of Wisconsin, in Madison, WI, has approved a Phase I study of its target activated pro-drug, G-202, for the treatment of cancer. The FDA (US Food and Drug Administration) approved the study in September. GenSpera expects to enroll the first study patient early in the first quarter of 2010.
Rosetta Genomics, Ltd., a leading developer and provider of microRNA-based molecular diagnostics, announces that results from a joint study by researchers at the Institutes of Oncology, Davidoff Center, Rabin Medical Center, Beilinson Hospital and Golda-Hasharon Hospital in Petach-Tikva, Israel show that in post-resection gastric cancer patients microRNAs may serve to predict the risk of recurrence.
› Verified 9 days ago
| Entity Name | Sandusky Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770907859 PECOS PAC ID: 3274895271 Enrollment ID: O20180402000752 |
News Archive
New exchange plan enrollees spent less on medications in the first quarter of 2015 compared to the same time a year ago, according to the third edition of the Express Scripts Exchange Pulse report, released today.
Overweight or obese women with the mentality that they are "eating for two" are more likely to experience excessive weight gain while pregnant, according to researchers at Penn State College of Medicine.
According to Simon Stevens, Chief Executive of NHS England, the NHS is looking at an epidemic of mental ill health among children and teenagers as an after effect of social media.
GenSpera, Inc. announced today that the Institutional Review Board (IRB) at the University of Wisconsin, in Madison, WI, has approved a Phase I study of its target activated pro-drug, G-202, for the treatment of cancer. The FDA (US Food and Drug Administration) approved the study in September. GenSpera expects to enroll the first study patient early in the first quarter of 2010.
Rosetta Genomics, Ltd., a leading developer and provider of microRNA-based molecular diagnostics, announces that results from a joint study by researchers at the Institutes of Oncology, Davidoff Center, Rabin Medical Center, Beilinson Hospital and Golda-Hasharon Hospital in Petach-Tikva, Israel show that in post-resection gastric cancer patients microRNAs may serve to predict the risk of recurrence.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Steven G Wilson, CRNA 250 N Shadeland Ave, Indianapolis, IN 46219-4959 Ph: () - | Steven G Wilson, CRNA 1111 Ronald Reagan Pkwy, Avon, IN 46123-7085 Ph: (317) 577-4200 |
News Archive
New exchange plan enrollees spent less on medications in the first quarter of 2015 compared to the same time a year ago, according to the third edition of the Express Scripts Exchange Pulse report, released today.
Overweight or obese women with the mentality that they are "eating for two" are more likely to experience excessive weight gain while pregnant, according to researchers at Penn State College of Medicine.
According to Simon Stevens, Chief Executive of NHS England, the NHS is looking at an epidemic of mental ill health among children and teenagers as an after effect of social media.
GenSpera, Inc. announced today that the Institutional Review Board (IRB) at the University of Wisconsin, in Madison, WI, has approved a Phase I study of its target activated pro-drug, G-202, for the treatment of cancer. The FDA (US Food and Drug Administration) approved the study in September. GenSpera expects to enroll the first study patient early in the first quarter of 2010.
Rosetta Genomics, Ltd., a leading developer and provider of microRNA-based molecular diagnostics, announces that results from a joint study by researchers at the Institutes of Oncology, Davidoff Center, Rabin Medical Center, Beilinson Hospital and Golda-Hasharon Hospital in Petach-Tikva, Israel show that in post-resection gastric cancer patients microRNAs may serve to predict the risk of recurrence.
› Verified 9 days ago
Tanner J Hulin, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1111 Ronald Reagan Pkwy, Avon, IN 46123 Phone: 317-577-4200 Fax: 317-577-4200 |